112 related articles for article (PubMed ID: 22375802)
1. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling.
Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ
J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802
[TBL] [Abstract][Full Text] [Related]
2. Software for quantitative proteomic analysis using stable isotope labeling and data independent acquisition.
Huang X; Liu M; Nold MJ; Tian C; Fu K; Zheng J; Geromanos SJ; Ding SJ
Anal Chem; 2011 Sep; 83(18):6971-9. PubMed ID: 21834580
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics using 16O/18O labeling and linear ion trap mass spectrometry.
López-Ferrer D; Ramos-Fernández A; Martínez-Bartolomé S; García-Ruiz P; Vázquez J
Proteomics; 2006 Apr; 6 Suppl 1():S4-11. PubMed ID: 16534745
[TBL] [Abstract][Full Text] [Related]
4. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic 18O-labeling strategies for quantitative proteomics.
Miyagi M; Rao KC
Mass Spectrom Rev; 2007; 26(1):121-36. PubMed ID: 17086517
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic labeling with 18O for comparative proteomics studies: preparation of 18O-labeled peptides and the 18O/16O peptide mixture.
Fenselau C; Yao X
Methods Mol Biol; 2007; 359():135-42. PubMed ID: 17484115
[TBL] [Abstract][Full Text] [Related]
7. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
[TBL] [Abstract][Full Text] [Related]
9. Differential proteomics based on 18O labeling to determine the cyclin dependent kinase 9 interactome.
Bezstarosti K; Ghamari A; Grosveld FG; Demmers JA
J Proteome Res; 2010 Sep; 9(9):4464-75. PubMed ID: 20593818
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar molecular signature of pluripotent stem cells.
Pliss A; Kuzmin AN; Kachynski AV; Jiang H; Hu Z; Ren Y; Feng J; Prasad PN
Anal Chem; 2013 Apr; 85(7):3545-52. PubMed ID: 23458184
[TBL] [Abstract][Full Text] [Related]
11. Global proteome analyses of SILAC-labeled skin cells.
Sprenger A; Küttner V; Bruckner-Tuderman L; Dengjel J
Methods Mol Biol; 2013; 961():179-91. PubMed ID: 23325643
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media.
Prowse AB; McQuade LR; Bryant KJ; Marcal H; Gray PP
J Proteome Res; 2007 Sep; 6(9):3796-807. PubMed ID: 17655345
[TBL] [Abstract][Full Text] [Related]
13. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.
Jin J; Kwon YW; Paek JS; Cho HJ; Yu J; Lee JY; Chu IS; Park IH; Park YB; Kim HS; Kim Y
J Proteome Res; 2011 Mar; 10(3):977-89. PubMed ID: 21175196
[TBL] [Abstract][Full Text] [Related]
14. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
Muñoz J; Heck AJ
Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
[TBL] [Abstract][Full Text] [Related]
16. Latest developments in sample treatment for 18O-isotopic labeling for proteomics mass spectrometry-based approaches: a critical review.
Capelo JL; Carreira RJ; Fernandes L; Lodeiro C; Santos HM; Simal-Gandara J
Talanta; 2010 Feb; 80(4):1476-86. PubMed ID: 20082805
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
18. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards.
Ishihama Y; Sato T; Tabata T; Miyamoto N; Sagane K; Nagasu T; Oda Y
Nat Biotechnol; 2005 May; 23(5):617-21. PubMed ID: 15834404
[TBL] [Abstract][Full Text] [Related]
19. Trypsin immobilization on hairy polymer chains hybrid magnetic nanoparticles for ultra fast, highly efficient proteome digestion, facile 18O labeling and absolute protein quantification.
Qin W; Song Z; Fan C; Zhang W; Cai Y; Zhang Y; Qian X
Anal Chem; 2012 Apr; 84(7):3138-44. PubMed ID: 22413971
[TBL] [Abstract][Full Text] [Related]
20. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
